- : Ms Word, Ms Word Format
- : 65 Pages
- : ₦10,000
- : 1-5 Chapters
- Click to DOWNLOAD Materials
ASSESSING THE IMPACT OF FINTECH ON PHARMACEUTICAL COMPANY INVESTMENT DECISIONS.
Abstract:
The rapid advancement of Financial Technology (FinTech) has transformed the way businesses operate across various industries, including the pharmaceutical sector. This abstract aims to provide an overview of the research conducted to assess the impact of FinTech on investment decisions within pharmaceutical companies.
The study recognizes that the pharmaceutical industry is highly regulated, capital-intensive, and relies heavily on research and development (R&D) investments. Traditionally, pharmaceutical companies have employed conventional financial tools and strategies to evaluate potential investments. However, the emergence of FinTech has introduced innovative technologies and platforms that have the potential to enhance investment decision-making in this industry.
Through a comprehensive literature review and empirical analysis, the study investigates the following key areas:
FinTech-based Investment Evaluation: The research explores how FinTech tools, such as predictive analytics, artificial intelligence (AI), and blockchain, have influenced the evaluation process of investment opportunities in the pharmaceutical industry. It examines how these technologies have improved the accuracy of financial forecasting, risk assessment, and due diligence processes.
Access to Capital: The study examines how FinTech has facilitated improved access to capital for pharmaceutical companies. It explores how crowdfunding platforms, peer-to-peer lending, and digital asset offerings have provided alternative sources of funding for pharmaceutical research, development, and expansion initiatives.
Transaction Efficiency: The research investigates how FinTech has streamlined transaction processes within the pharmaceutical industry. It explores the impact of digital payment systems, smart contracts, and blockchain technology on reducing transaction costs, enhancing transparency, and improving supply chain management.
Regulatory Compliance: The study acknowledges the significant regulatory framework governing the pharmaceutical industry. It assesses the impact of FinTech on regulatory compliance and examines how technologies such as RegTech (Regulatory Technology) and SupTech (Supervisory Technology) have facilitated compliance with industry-specific regulations and reporting requirements.
The research employs a mixed-methods approach, combining qualitative and quantitative data analysis. It utilizes financial data, case studies, and interviews with industry professionals to provide a comprehensive evaluation of the impact of FinTech on pharmaceutical company investment decisions.
The findings of this study aim to contribute to the existing literature on the intersection of FinTech and the pharmaceutical industry. The research findings may assist pharmaceutical companies, investors, and policymakers in understanding the opportunities and challenges associated with incorporating FinTech into investment decision-making processes. Ultimately, it is expected that the research will shed light on how FinTech can be effectively leveraged to enhance investment strategies, improve operational efficiency, and drive innovation within the pharmaceutical sector.
